Alpha 2.0
Login Register
» Authors » Jakob Mollenbach Moller

Jakob Mollenbach Moller

Explore the profile of Jakob Mollenbach Moller including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 23
Followers 0
Related Specialties
Rheumatology
Radiology
Top 10 Co-Authors
Mikkel Ostergaard
Ole Rintek Madsen
Niels Steen Krogh
Merete Lund Hetland
Mikael Boesen
Henrik Rogind
Jesper Norregaard
Susanne Juhl Pedersen
Stylianos Georgiadis
Cecilie Heegaard Brahe
Published In
Rheumatology (Oxford)
RMD Open
BJR Open
J Rheumatol
Ann Rheum Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
MRI-based synthetic CT: a new method for structural damage assessment in the spine in patients with axial spondyloarthritis - a comparison with low-dose CT and radiography
Willesen S, Hadsbjerg A, Moller J, Vladimirova N, Vora B, Seven S, et al.
Ann Rheum Dis . 2024 Mar; 83(6):807-815. PMID: 38490729
Objective: To investigate the ability of MRI-based synthetic CT (sCT), low-dose CT (ldCT) and radiography to detect spinal new bone formation (NBF) in patients with axial spondyloarthritis (axSpA). Methods: Radiography...
2.
Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial
Moller-Bisgaard S, Horslev-Petersen K, Ornbjerg L, Ejbjerg B, Hetland M, Moller J, et al.
RMD Open . 2024 Mar; 10(1). PMID: 38490697
Objective: To investigate whether a 2-year MRI treat-to-target strategy targeting the absence of osteitis combined with clinical remission, compared with a conventional treat-to-target strategy targeting clinical remission only (IMAGINE-rheumatoid arthritis...
3.
Occurrence and Prediction of Flare After Tapering of Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis
Wetterslev M, Georgiadis S, Christiansen S, Pedersen S, Sorensen I, Hetland M, et al.
J Rheumatol . 2023 Oct; PMID: 37839816
Objective: Patients with axial spondyloarthritis (axSpA) in clinical remission tapered tumor necrosis factor inhibitor (TNFi) therapy according to a clinical guideline. Over a 2-year follow-up period, we aimed to investigate...
4.
Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors
Terslev L, Ostergaard M, Georgiadis S, Brahe C, Ellegaard K, Dohn U, et al.
RMD Open . 2022 Dec; 8(2). PMID: 36549857
Objective: To identify predictors of flare in a 2-year follow-up study of patients with rheumatoid arthritis (RA) in sustained clinical remission tapering towards withdrawal of biological disease-modifying anti-rheumatic drugs (bDMARDs)....
5.
Tapering of TNF inhibitors in axial spondyloarthritis in routine care - 2-year clinical and MRI outcomes and predictors of successful tapering
Wetterslev M, Georgiadis S, Sorensen I, Pedersen S, Christiansen S, Hetland M, et al.
Rheumatology (Oxford) . 2021 Oct; 61(6):2398-2412. PMID: 34636846
Objectives: In a 2-year follow-up study of patients with axial spondyloarthritis (axSpA) in clinical remission who tapered TNF inhibitor (TNFi) treatment according to a clinical guideline, we aimed to investigate...
6.
Do tender joints in active psoriatic arthritis reflect inflammation assessed by ultrasound and magnetic resonance imaging?
Felbo S, Wiell C, Ostergaard M, Poggenborg R, Boyesen P, Hammer H, et al.
Rheumatology (Oxford) . 2021 Apr; 61(2):723-733. PMID: 33895799
Objective: To investigate the association between clinical joint tenderness and intra- and periarticular inflammation as assessed by ultrasound and MRI in patients with active PsA and to explore if the...
7.
Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission
Terslev L, Brahe C, Hetland M, Georgiadis S, Ellegaard K, Juul L, et al.
Rheumatology (Oxford) . 2021 Mar; 60(12):5549-5559. PMID: 33748831
Objective: To assess the ability of ultrasound to predict successful tapering and successful discontinuation of biological DMARDs (bDMARDs) at the 2-year follow-up in RA patients in sustained remission. Methods: Patients...
8.
Repeatability and reproducibility of MRI apparent diffusion coefficient applied on four different regions of interest for patients with axial spondyloarthritis and healthy volunteers scanned twice within a week
Moller J, Ostergaard M, Thomsen H, Hangaard S, Sorensen I, Madsen O, et al.
BJR Open . 2021 Jan; 2(1):20200004. PMID: 33409446
Objectives: The apparent diffusion coefficient (ADC) may be used as a biomarker for diagnosis and/or monitoring treatment response in patients with axial spondyloarthritis (axSpA), but this requires reliable ADC measurements....